Acumen Pharmaceuticals, Inc.
Disclosed SEC business address
1210-1220 WASHINGTON STREET, SUITE 210, NEWTON, MA, 02465
Acumen Pharmaceuticals, Inc. (ticker ABOS, CIK 0001576885) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Biological Products, (No Diagnostic Substances) (SIC 2836). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.
You've reached this month's free company deep views
The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.
Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.
Sources
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:20:35.610715+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:20:39.993249+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:20:44.050049+00:00
- U.S. Securities and Exchange Commission, EDGAR · filing document · retrieved 2026-10-31T05:20:32.785286+00:00
Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.